From: Enhanced tyrosine sulfation is associated with chronic kidney disease-related atherosclerosis
 | Univariate | Multivariable | ||
---|---|---|---|---|
OR | P value | OR | P value | |
Plasma O-sulfotyrosine /10 | 1.029 (1.010–1.048) | 0.002 | 1.028 (1.010–1.047) | 0.003 |
WBC (109/L) | 0.974 (0.730–1.299) | 0.856 | - |  |
Neutrophil (%) | 1.031 (0.987–1.078) | 0.172 | - |  |
BUN (mmol/L) | 1.024 (0.970–1.081) | 0.387 | - |  |
CRE (μmol/L) | 1.000 (0.999–1.002) | 0.533 | - |  |
UA (μmol/L) | 1.000 (0.996–1.004) | 0.937 | - |  |
CysC (mg/L) | 1.139 (0.931–1.393) | 0.205 | - |  |
eGFR (mL/min/1.73 m2) | 0.981 (0.958–1.003) | 0.093 | - |  |
TC (mmol/L) | 0.883 (0.617–1.263) | 0.359 | - |  |
TG (mmol/L) | 0.793 (0.483–1.302) | 0.495 | - |  |
HDL-C (mmol/L) | 0.588 (0.121–2.867) | 0.511 | - |  |
LDL-C (mmol/L) | 0.956 (0.610–1.500) | 0.846 | - |  |
hsCRP (mg/L) | 1.019 (0.992–1.047) | 0.163 | - |  |